Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C.

PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

2.

Pro-inflammatory Monocyte Phenotype and Cell-Specific Steroid Signaling Alterations in Unmedicated Patients With Major Depressive Disorder.

Hasselmann H, Gamradt S, Taenzer A, Nowacki J, Zain R, Patas K, Ramien C, Paul F, Wingenfeld K, Piber D, Gold SM, Otte C.

Front Immunol. 2018 Nov 23;9:2693. doi: 10.3389/fimmu.2018.02693. eCollection 2018.

3.

Image fusion using the two-dimensional-three-dimensional registration method helps reduce contrast medium volume, fluoroscopy time, and procedure time in hybrid thoracic endovascular aortic repairs.

Ahmad W, Hasselmann HC, Galas N, Majd P, Brunkwall S, Brunkwall JS.

J Vasc Surg. 2018 Oct 24. pii: S0741-5214(18)31994-3. doi: 10.1016/j.jvs.2018.07.043. [Epub ahead of print]

PMID:
30528407
4.

Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework.

Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, Otte C.

Lancet Psychiatry. 2017 Sep;4(9):725-732. doi: 10.1016/S2215-0366(17)30153-0. Epub 2017 Apr 7. Review.

PMID:
28396067
5.
6.

Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor.

de Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MH, Hasselmann H, Kliegel D, Joëls M.

J Neuroendocrinol. 2016 Aug;28(8). doi: 10.1111/jne.12379. Review.

PMID:
26970338
7.

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.

Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM.

Mult Scler. 2016 Oct;22(11):1476-1484. Epub 2016 Jan 8.

PMID:
26746809
8.

Interaction of Ketamine and Cannabis in Bipolar Disorder.

Hasselmann H.

Biol Psychiatry. 2016 May 1;79(9):e73-4. doi: 10.1016/j.biopsych.2015.07.014. Epub 2015 Jul 29. No abstract available.

PMID:
26382597
9.

Short-term escitalopram treatment and hippocampal volume.

Godlewska BR, Hasselmann HW, Igoumenou A, Norbury R, Cowen PJ.

Psychopharmacology (Berl). 2014 Dec;231(23):4579-81. doi: 10.1007/s00213-014-3771-3. Epub 2014 Oct 18. No abstract available.

10.

Scopolamine and depression: a role for muscarinic antagonism?

Hasselmann H.

CNS Neurol Disord Drug Targets. 2014;13(4):673-83. Review.

PMID:
24938776
11.

Ketamine as antidepressant? Current state and future perspectives.

Hasselmann HW.

Curr Neuropharmacol. 2014 Jan;12(1):57-70. doi: 10.2174/1570159X113119990043.

12.

The construction and cloning of synthetic genes coding for artificial proteins and expression studies to obtain fusion proteins.

Biernat J, Hasselmann H, Hofer B, Kennedy N, Köster H.

Protein Eng. 1987 Aug-Sep;1(4):345-51.

PMID:
2854258
13.

[Seconds phenomenon and mistletoe, a surprisingly effective therapeutic combination].

HASSELMANN H.

Hippokrates. 1961 Aug 15;32:603-5. German. No abstract available.

PMID:
13712175

Supplemental Content

Loading ...
Support Center